NICE Backs EUSA Pharma’s Qarziba

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2KXnXbr on July 15, 2018 at 07:02PM The U.K.’s National Institute for Health and Care Excellence (NICE) in a final draft guidance recommended EUSA Pharma’s Qarziba, a neuroblastoma treatment, pharmaphorum reports. NICE’s recommendation comes after a first draft guidance this year in which the government body floated Qarziba […]

More Details on Recent Avalere Survey

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2LimPil on July 15, 2018 at 06:32PM There has been a marked increase in how many health plans are having active conversations about outcomes-based contracting within their organization, Avalere’s recent survey found. According to a Healthcare Dive report, more than one-third of the 50 respondents — composed of […]

Kidney exchange is fragmented in the U.S.

from Market Design at http://bit.ly/2mhdCbD on July 15, 2018 at 01:23PM Market Failure in Kidney Exchange Nikhil Agarwal, Itai Ashlagi, Eduardo Azevedo, Clayton R. Featherstone, Ömer Karaduman NBER Working Paper No. 24775Issued in June 2018 Abstract: "We show that kidney exchange markets suffer from traditional market failures that can be fixed to increase transplants by 25%-55%. First, we document […]

Avalere Study: Health Plans Warming to Outcomes-Based Contracts

from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2KUV8g7 on July 14, 2018 at 05:25PM Health plans are becoming more interested in outcomes-based contracts, according to a new survey from Avalere, and “internal conversations” about them are happening more often. Avalere in a press release says 25 percent of the surveyed health plans have implemented outcomes-based […]